Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial
Stefano Cascinu(Vita-Salute San Raffaele University), Francesco Perrone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alberto Sobrero(Ospedale Policlinico San Martino), Francesca Negri(University of Parma), Ciro Gallo(University of Campania "Luigi Vanvitelli"), Rossana Berardi(Marche Polytechnic University), Domenica Ferrara(Ospedale San Carlo), Andrea Spallanzani(University of Modena and Reggio Emilia), Alessandro Bittoni(Marche Polytechnic University), Stefania Mosconi(Ospedale Papa Giovanni XXIII), Roberto Bianco(Federico II University Hospital), Alberto Zaniboni(Fondazione Poliambulanza Istituto Ospedaliero), Silvia Noventa(Fondazione Poliambulanza Istituto Ospedaliero), Giordano Beretta(Humanitas Gavazzeni), Maria Carmela Piccirillo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alberto Morabito(University of Milan), Roberto Labianca(Ospedale Papa Giovanni XXIII), Roberta Marciano, Daris Ferrari, Andrea Casadei‐Gardini(Vita-Salute San Raffaele University), Domenico Bilancia(Azienda Ospedaliera Ospedale San Carlo Borromeo), Silvana Leo(Ospedale Vito Fazzi), Cristina Mosconi(Azienda USL di Bologna), Luigi Cavanna(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Maria Banzi(Azienda Ospedaliera S.Maria)
Cited by 17
Related Papers
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k